(Q41231006)

28 September 2017

1 reference

title

ISCOMs (immunostimulating complexes): the first decade (English)

1 reference

28 September 2017

Barr IG

1

1 reference

28 September 2017

Mitchell GF

series ordinal

2

1 reference

28 September 2017

language of work or name

1 reference

1 February 1996

1 reference

Immunology & Cell Biology

28 September 2017

1 reference

28 September 2017

74

1 reference

28 September 2017

8-25

1 reference

28 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.1996.2

28 September 2017

0 references

cites work

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Quaternary structure of the immunostimulating complex (iscom).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Influenza virus ISCOMs: biochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The ISCOM: an immunostimulating complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The iscom structure as an immune-enhancing moiety: experience with viral systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Electron microscopic observations on Rous sarcoma virus and cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Action of saponin on biological cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Iscom immunization with synthetic peptides representing measles virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Bovine leukaemia virus ISCOMs: biochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Controlled organization of multimolecular complexes of enveloped virus glycoproteins: study of immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Local antibody forming cell responses to the Hitchner B1 and Ulster strains of Newcastle disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Characterization of immunostimulating complexes (ISCOMS) of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Inflammatory response and antigen localization following immunization with influenza virus ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Crossrecognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The role of adjuvants in retroviral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

NIH conference. HIV vaccine development: a progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Delivery of pseudorabies virus envelope antigens enclosed in immunostimulating complexes (ISCOMs); elicitation of neutralizing antibody and lymphoproliferative responses in swine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Immunogenicity of a hybrid Plasmodium falciparum malaria antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Active-specific immunotherapy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Humoral immune response elicited in rats by measles viral membrane antigens presented in liposomes and ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Action of Saponin on Biological Cell Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Interactions between Immune-Stimulating Complexes (ISCOMs) and Peritoneal Mononuclear Leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

ISCOMs and immunostimulation with viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Studies on the substructure of togaviruses. I. Effect of urea, deoxycholate, and saponin on the Sindbis virion

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Adjuvant activity of QS-21 isomers

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Adjuvanticity and ISCOM formation by structurally diverse saponins

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

STRUCTURE AND ASSEMBLY OF MACROMOLECULAR LIPID COMPLEXES COMPOSED OF GLOBULAR MICELLES

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

On the structure of immune-stimulating saponin-lipid complexes (iscoms)

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Vaccination of rabbits with a bovine herpesvirus type 1 subunit vaccine: adjuvant effect of ISCOMs

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Characterization of an iscom prepared with envelope glycoproteins of bovine herpesvirus type 1

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immunizing effects in mice of two Toxoplasma gondii iscom preparations

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization aga

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria falciformis in ISCOMs

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Conjugation of synthetic peptides to carrier iscoms: factors affecting the immunogenicity of the conjugate

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Synergistic effect of detergents and aluminium phosphate on the humoral immune response to bacterial and viral membrane proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Formation and characterization of FeLV ISCOMs

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Classical and new approaches to adjuvant use in domestic food animals

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Efficacy of various non-oily adjuvants in immunization against the Aujeszky's disease (pseudorabies) virus.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Lipid A and immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Neospora caninum in dogs: detection of antibodies by ELISA using an iscom antigen

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Effect of DETOX as an adjuvant for melanoma vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.2

7 January 2021

Identifiers

DOI

10.1038/ICB.1996.2

1 reference

Dimensions Publication ID

28 September 2017

0 references

1 reference